Study Stopped
Beacuse of unexpected administrative barriers, only 5 cases were enrolled in a year.
X-Ray Computed Tomography and Blood Reactive Oxygen Species Level
Effect of X-Ray Computed Tomography Examination on the Blood Reactive Oxygen Species Level in Apparently Healthy Adults
1 other identifier
observational
60
1 country
1
Brief Summary
The clinically widely used X-ray computed tomography examination has a low-grade radiation effect and recently has attracted much attention concerning the possible adverse effects of radiation on human body \[ref. 1-5\]. The radiation is harmful to human tissues and cells mainly because it can interact with water (which makes up to 80% of cells) to generate reactive oxygen species (ROS), especially the formation of hydroxyl radicals. So far as we can reach, there is no report concerning the relation between X-ray computed tomography examination and the blood ROS concentration. Therefore, we wish to conduct this study to clarify if the routinely applied X-ray computed tomography examination may induce a higher concentration of ROS in the peripheral blood. Study subjects will be participants of health check program at our hospital. The only enrollment condition will be a scheduled X-ray computed tomography examination for either lung (20 cases) or heart (20 cases) of the study subject. Another 20 participants receiving health check program without X-ray computed tomography examination will be included as the control group. The formal consent will be delivered to the participants of health check program several days before their admission for health check and will be retrieved before the proceeding of health check. Measurements and comparison of ROS concentration will be performed in the sampled peripheral blood before and after the performance of X-ray computed tomography examination during a regular health check program. Totally 120 blood samples will be collected from included 60 study subjects within 3 months. Reactive oxygen species(ROS)levels will be measured by a chemiluminescence (CL) analysing system (CLD-110, Tohoku Electronic Industrial, Sendai, Japan).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started May 2008
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2008
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2008
CompletedFirst Submitted
Initial submission to the registry
July 9, 2008
CompletedFirst Posted
Study publicly available on registry
July 11, 2008
CompletedMay 19, 2009
March 1, 2008
2 months
July 9, 2008
May 17, 2009
Conditions
Keywords
Study Arms (3)
1
Twenty subjects receiving health check program without X-ray computed tomography examination will be included as the control group.
2
Twenty subjects receiving health check program including X-ray computed tomography examination of lung will be included as the treatment group-1.
3
Twenty subjects receiving health check program including X-ray computed tomography examination of heart will be included as the treatment group-2.
Eligibility Criteria
participants of health check program at our hospital
You may qualify if:
- Participants of health check program at our hospital who will receive a scheduled X-ray computed tomography examination for either lung (20 cases) or heart (20 cases).
You may not qualify if:
- Those whose age are under 50 or above 70 year-olds will be excluded.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
NTUH
Taipei, 10016, Taiwan
Biospecimen
only peripheral blood will be collected for measurement of reactive oxygen species.
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Zei-Shung Huang, MD, PhD
NTUH
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
July 9, 2008
First Posted
July 11, 2008
Study Start
May 1, 2008
Primary Completion
July 1, 2008
Study Completion
July 1, 2008
Last Updated
May 19, 2009
Record last verified: 2008-03